1,664 filings
Page 49 of 84
8-K
1ir gpx4b1s5cg8z
16 Dec 09
Other Events
12:00am
8-K
1i4kyf2b
16 Dec 09
Other Events
12:00am
8-K
oqr4zz6gf85axs3n
14 Dec 09
Other Events
12:00am
8-K
bx0vt xdhl8
11 Dec 09
Other Events
12:00am
8-K
te2wb1mioro3js
4 Dec 09
Other Events
12:00am
8-K
d7job8j1m 6wrops
4 Dec 09
Other Events
12:00am
CORRESP
mhyypvs9znq1vsyscw2
3 Dec 09
Correspondence with SEC
12:00am
8-K
mbbr1w
27 Nov 09
Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
12:00am
8-K
ql7cp2p87j rvethy6
27 Nov 09
Other Events
12:00am
UPLOAD
xiui7f48tvf36cje0zyt
20 Nov 09
Letter from SEC
12:00am
8-K
8bgoppeb3 iryej
13 Nov 09
Other Events
12:00am
8-K
tqt gmbjq
4 Nov 09
Other Events
12:00am
8-K
yc5qh64mtwomg7gnb
4 Nov 09
Other Events
12:00am
8-K
0esoz
4 Nov 09
Departure of Directors or Certain Officers
12:00am
8-K
20ygwplbswz082
4 Nov 09
Other Events
12:00am
8-K
jr0 v2qixmae
30 Oct 09
Shire continues to deliver excellent growth from core products
12:00am
8-K
08s4 qlpx1
28 Oct 09
FDA Determines VYVANSE® was Properly Granted Five-Year Market Exclusivity
12:00am
8-K
2uqmnoxphyvfiyt3
23 Oct 09
Other Events
12:00am
8-K
kd4xr51z5j5olhdin9
23 Oct 09
Other Events
12:00am